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ABSTRACT

Heart failure and high mortality rates are associated with severe sepsis.
Recently, focus has been on mitochondrial ultrastructural changes and function
due to sepsis and sepsis-related pathologies. Chopra et al. (2011) has provided
data showing the involvement of the mitochondrial-mediated intrinsic apoptosis
cascade in regulating adult rat ventricular myocyte (ARVM) dysfunction in sepsis.
Experimental endotoxemia has shown mitochondrial membrane potential
collapse, membrane permeability changes and release of cytochrome C to be
indicators of mitochondrial dysfunction. Outer mitochondrial membrane (OMM)
permeability is controlled by Bax translocation, resulting Voltage Dependent
Anion Channels (VDACs) pores in the OMM and activation of mitoKATP channels
in the inner mitochondrial membrane. Endotoxins can induce mitochondrial
damage and there is a correlation between the severity of sepsis and
mitochondrial damage and dysfunction. Since the progression of sepsis occurs
from vascular dysfunction to organ dysfunction, in the current study we examined
mitochondrial dysfunction in endotoxic HUVEC cells. This study has provided
evidence for 5HD, a putative mitoKATP blocker, in the preservation of ∆Ψm in
endotoxic HUVEC. Additionally, 5HD appears to prevent Apaf-1 expression and
reduce H2O2 generation in endotoxic HUVEC.
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INTRODUCTION
Mitochondria: An Energy Source for Cells
Mitochondria serve as a significant source of energy for cells due to the
considerable amounts of ATP produced during aerobic respiration. Mitochondria
facilitate the use of oxygen by cells to generate large quantities of ATP compared
to lower amounts under anaerobic conditions. Energy sources such as
carbohydrates, lipids and proteins are broken down through the process of
glycolysis which produces two molecules of ATP per one event of glycolysis
under anaerobic conditions and lactic acid accumulation (5). However, under
aerobic states, cells further oxidize these energy sources through the citric acid
cycle to generate electron carriers such as NADPH and FADH2. Mitochondria
enable the use of these electron carriers to produce over thirty ATP molecules
through the process of oxidative phosphorylation.
An electron transport chain (ETC) also exists along the inner mitochondrial
membrane (IMM). The ETC serves to generate ATP through electron donation
from electron carriers NADH and FADH2 and formation of a proton gradient
across the IMM (34). Four protein complexes form the ETC to shuttle electrons
donated by NADH and FADH2, three of which also transport protons across the
IMM into the intermembrane space: complexes I, III and IV (34), (44). Transport
of electrons from NADH and FADH2 to ubiquinone, or coenzyme Q, is
accomplished by complex I (NADH/ubiquinone oxidoreductase) and complex II,
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respectively. Electrons are then transported from ubiquinone to complex III and
from complex III to IV by cytochrome C to ultimately reduce molecular oxygen to
water. Protons are simultaneously transferred with electron transport from the
mitochondrial matrix to the intermembrane space by complex I, III and IV. It is the
influx of protons from the intermembrane space into the mitochondrial matrix
through ATP synthase which provides the energy for ATP production by
mitochondria. This ATP can either remain in the mitochondrial matrix or be
transported into the intermembrane space by an adenine nucleotide translocator
(ANT) and into the cytoplasm by a voltage-dependent anion channel (VDAC)
located in the outer mitochondrial membrane (OMM) (44),(5).

Mitochondria: Significance in Pathogenic Disorders
Mitochondrial dysfunction contributes to several physiological disorders due to
the essential role in energy supply. Normal mitochondrial activity produces
harmful compounds and the balance between generation and neutralization of
these compounds is fundamental. Mechanisms exist in mitochondria to maintain
stability in the presence of various by-products; however, distinct pathologies can
have deleterious effects on these mechanisms. However, mitochondria also have
many other functions in addition to energy production. For example, specific
mitochondrial enzymes exist to act as defense mechanisms which are also
susceptible to disruption. Defects in mitochondrial function and associated
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pathologies can cause oxidative stress and metabolic disorders in addition to a
diminished supply of ATP.

Mitochondria and Diabetic Cardiomyopathy
Diabetic cardiomyopathy can be characterized by left ventricular dysfunction
and hypertrophy in diabetic individuals (69). Cardiac contractility diminishes due
to the influence of pathological morphological and functional changes which
occur in the heart in diabetic cardiomyopathy. Zhang et al. have provided
evidence of mitochondrial ultrastructural alterations in mitochondria isolated from
cardiac tissue of a murine model of type 1 diabetes, as well as demonstrated
disrupted mitochondrial membrane potential (ΔΨM) in cardiomyocytes exposed to
high levels of glucose (71). Moreover, it is mitochondria-derived ATP through
oxidative phosphorylation which supplies the majority of the energy required for
cardiac function (22). Up to 70% of the total ATP received is used for contraction
of cardiac myocytes alone (22). The bioenergetics of cardiac physiology requires
a substantial and consistent supply of ATP which is limited in diabetic individuals.
Insulin is responsible for the insertion of glucose transporters, GLUT1 and
GLUT4, into cardiac cell membranes. Expression of GLUT4 is known to be
reduced in individuals with diabetes (69). Hyperglycemia persists and ATP
production is decreased due to the lack of glucose uptake by cardiac cells in
these individuals (69). The fact that

4

fatty acids remain the primary source of ATP generation by cardiac myocytes
also allows for mitochondrial dysfunction to be recognized in diabetic
cardiomyopathy as an abnormal buildup of lipids is characteristic of this condition
(22), (25). Evidently, mitochondria remain a crucial organelle for normal cardiac
function taking into consideration the energetic demands of this organ.
Pathological conditions which lead to mitochondrial dysfunction and alterations in
morphology can alter the normal heart function.

Reactive Oxygen Species and Related Pathologies
For mitochondria to meet energetic demands, a steady supply of oxygen is
necessary to accept electrons at the termination of the electron transport chain.
Mitochondrial oxygen consumption under non-pathological conditions results in
the production of reactive oxygen species (ROS) which, if neutralized, remain
unproblematic. However, mitochondrial dysfunction and subsequent ROS
generation have been linked to obesity and insulin resistance (6), (44).
Uncoupling protein 1 (UCP1) uncouples ATP synthesis from the proton gradient
generated during oxidative phosphorylation to facilitate the clearance of ROS (6).
UCP1 is located in the inner mitochondrial membrane and mitochondrial
membrane disruption may eliminate its activity in ROS disposal. Moreover, the
balance between generation and removal of ROS through mitochondrial
uncoupling can be disturbed in the event of excessive nutrient consumption and
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overabundant substrate availability for ATP generation through mitochondria (6),
(44). Consequently, oxidative damage and cell death can occur (6). Excessive
nutrient availability for prolonged periods of time can also lead to insulin
resistance (6), (44). The essential activities of mitochondria are also
accompanied by the generation of destructive by-products; however,
mitochondrial mechanisms exist to control the damaging effects. Chronic
pathological conditions may abolish these mechanisms and lead to cellular
damage and death.
Aldehyde Dehydrogenase 2 Deficiency
Aldehyde dehydrogenase 2 (ALDH2) is a mitochondrial enzyme which exists
in the matrix and acts during the rate-limiting step of ethanol metabolism to
convert acetaldehyde to acetic acid (11). Due to the hydrophilic nature of
acetaldehyde, accumulation of this compound from defects in ALDH2 causes
adverse reactions in the cell following passage through the lipid bilayers (11),
(19), (2). Consequently, ALDH2 participates in defense against damage from
oxidative stress. For example, ALDH2 has a crucial function in neutralizing the
highly reactive aldehyde products of lipid peroxidation, 4-hydroxynonenal (4HNE) and malondialdehyde (MDA) (11), (19), (2). Deficiency in mitochondrial
aldehyde dehydrogenase has also been linked to several pathologies. Neuron
cell death and reduced cognitive ability have been presented as the results of
reactive aldehyde accumulation in the brain (36). Particularly, 4-HNE has been
implicated in Alzheimer’s disease (36). It has been suggested that ALDH2, which
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acts to convert the reactive products of lipid peroxidation to less injurious
compounds, plays a key role in neuroprotection (19). Indeed, upregulation of
ALDH2 may be considered a marker of improved cognitive function in animal
models of Alzheimer’s disease (36). Further, D’Souza et al. have shown cognitive
deterioration in an age-dependent manner in a murine ALDH2 knockout model
(19). ALDH2 is also present in greater quantities in highly metabolic organs
which require plenty of oxidative phosphorylation, such as the heart and brain
indicating the need for protection from oxidative damage (11). Clearly, proper
mitochondrial function is necessary beyond the energetic demands for ATP
generation. Enzymes contained in these organelles provide a vital defensive
function as evidence shows that deleterious effects result from deficits in
mitochondrial aldehyde dehydrogenase activity.

Apoptosis and the Role of Mitochondria
Apoptosis is a form of cellular death which follows a specific and genetically
controlled procedure. The systematic activation of various proteins results in
destruction of the cell which can be recognized by characteristic changes in cell
morphology as well as protein expression. Two forms of apoptosis exist: the
intrinsic and extrinsic pathways. The extrinsic path of apoptosis requires the
activation of death receptors at the surface of cells (23).
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Mitochondria serve as the conduit through which the stress-induced intrinsic
pathway of apoptosis is carried out. Bak and Bax, pro-apoptotic members of the
Bcl-2 protein family, are inserted into the mitochondrial membrane to form the
mitochondrial permeability transition pore (64). Due to this disruption in the
mitochondrial membrane, cytochrome C is subsequently released from the
intermembrane space into the cytoplasm. Oligomerization of typically monomeric
apoptotic protease activating factor-1 (Apaf-1) occurs following hydrolysis of
dATP to dADP (54). Apaf-1 functions to bind released cytochrome C in the
cytoplasm to form the apoptosome. This structure, composed of seven Apaf-1
units and cytochrome C function to cleave procaspase-9 into its active form,
caspase-9. Activated caspase-9 proceeds to activate caspase-3 through
cleavage from the inactive procaspase-3 to result in destruction of the cell (54).
Degradation of the cell involves various processes such as DNA fragmentation,
shrinkage of the cell and protrusion of the plasma membrane. These
morphological changes are characteristic indicators of a cell undergoing
apoptosis through the mitochondrial-mediated pathway.

Mitochondrial Outer Membrane Permeabilization
Bax and Bak are Bcl-2 (B-cell lymphoma protein-2) family members and form
pores in the mitochondrial outer membrane in response to an apoptotic stimulus
through the intrinsic pathway (21), (72), (38). Homo-oligomerization occurs once
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Bax and Bak are activated and the BH3 (Bcl-2 homology) domain of one
molecule will interact with the hydrophobic groove of another activated molecule
(21). Bax, in monomeric form, primarily remains in the cytosol prior to the
apoptotic signal after which Bax translocates to the outer mitochondrial
membrane (OMM) to insert its transmembrane domain (21), (72). This contrasts
with Bak which perpetually remains anchored to the OMM. Bax and Bak
regulation mechanisms are unclear, however it is believed that these proteins are
detained in the cytosol by pro-survival proteins prior to their activation by an
apoptotic stimulus (21).
Voltage-dependent anion channels (VDACs) are considered the most
predominant outer mitochondrial membrane proteins responsible for ion and
metabolite flux ranging from 1.5-5 kDa in size (3), (43). Adenine nucleotide
translocase (ANT), a prevalent inner mitochondrial membrane protein, functions
in ADP import into the matrix and ATP export eventually to the cytosol (40). The
OMM pore has been previously thought to include VDACs and ANT (21), (3).
Evidence is lacking and inconsistent for a necessary role of VDACs in
mitochondrial permeability pore formation and function during apoptosis (3), (43).
Although, a regulatory role for ANT has been implicated with proposed pro- and
anti-apoptotic isoforms (3), (40), (8). Ultimately, the pores created in the
mitochondrial membrane are primarily established by Bcl-2 proteins and function
to release cytochrome C into the cytosol from the intermembrane space.
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Cytochrome C and the Apoptosome
Cytochrome C in healthy cells is a key component of the electron transport
chain and participates in substantial amounts of ATP generation. Yet, the
resulting mitochondrial dysfunction, apoptosome formation and caspase cascade
activation from cytochrome C release commits the cell to death (21), (72).
Cardiolipin (CL), an inner mitochondrial membrane (IMM) lipid, is known to
anchor cytochrome C to the IMM (38), (65). Accordingly, CL oxidation is thought
to lead to the release of cytochrome C from the IMM so that it may be
transported from the intermembrane space into the cytosol (38), (65), (73).
Further, data from Zhong et al. proposes that modulation of CL oxidation is a
mechanism used by cancer cells to evade apoptosis (73). Experimental evidence
by Zhang et al. also suggests that cytochrome C release into the cytosol requires
contact with Bax, interactions with the pore residues and can influence the pore
structure to facilitate release (72). Evidently, this systematic process of cell death
is controlled at multiple levels.
Constitutive, but low levels of Apaf-1 are present in cells, however, expression
can be increased by transcription factors E2F transcription factor 1 (E2F1) and
tumor-suppressor protein (p53) (54), (33). E2F1 phosphorylation, stabilization,
subsequent activation of APAF1 genes and apoptosis are known to occur
following DNA damage or serum starvation (33). The nucleotide-binding
oligomerization domain (NOD) of Apaf-1 facilitates binding between multiple units
of Apaf-1 to form the heptameric apoptosome structure (54), (65). The WD40
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(tryptophan-aspartate) repeats domain (WRD) possesses a regulatory function
as the binding of cytochrome C to this domain causes a conformational change
that allows procaspase-9 attachment (54), (65). Multiple Apaf-1 isoforms exist
ranging from 133-142 kDa with caspase recruitment domains (CARDs) located at
their N-terminus responsible for binding procaspase-9 (54). It is known that
dATP/ATP is necessary for Apaf-1 oligomerization, however, cytochrome C
binding is not dependent on the presence of dATP/ATP (54), (65). The
apoptosome provides the scaffold which permits the cleavage of procaspase-9 to
active caspase-9 (54), (65).

The Caspase Cascade and Cell Death
Caspases are cysteine-aspartic acid proteases which mainly cleave at the Cterminal end of aspartate residues (30). In particular, caspase-3 and caspase-7
are further classified as apoptotic effector caspases (30). Procaspases are the
inactive zymogen forms of caspases which are present in cells prior to cleavage
to active forms (30). Certain procaspases are expressed as monomers and later
form dimers after activation, or as dimers which require cleavage within the linker
region, nevertheless, active caspases ultimately function as dimers (30).
Apoptosis due to caspases is not limited to the intrinsic pathway as the extrinsic
pathway of cell death is also carried out by caspase-8, caspase-3 and caspase-7
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(30). Further, caspases can cause cell death through mechanisms other than
apoptosis. For example, the binding of LPS to inflammatory caspase-4 and
caspase-11, in response to bacterial infections, can result in activation,
oligomerization and inflammatory cell death (30).
Once bound to the apoptosome, procaspase-9 cleaves itself in order to
activate procaspase-3 and procaspase-7 (54), (9). It has been proposed that up
to four molecules of procaspase-9 attach to the apoptosome (54). Bretnall et al.
have proposed distinct roles for caspase-9, caspase-3 and caspase-7 in the
intrinsic apoptosis pathway (9). The data implies additional functions for caspase9 such as mitochondrial remodeling (9). Also, caspase-3 may inhibit the
production of reactive oxygen species as well as being the primary effector
caspase and caspase-7 may be responsible for cleavage of ECM proteins and
cell detachment (9). Nevertheless, the resulting effects of the caspase cascade
on the cell include shrinkage of the cell, DNA fragmentation, membrane blebbing
and exposure of phosphatidylserines to the extracellular environment (30), (9).
This controlled process of cell death ensures un-injurious degradation and
removal of damaged or unwanted cells.

Oxygen Free Radicals and Apoptosis
Oxygen free radicals exist as types of highly reactive oxygen-containing
molecules due to the possession of an unpaired electron. Similarly, reactive
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oxygen species (ROS) exist as a class of highly reactive oxygen-containing
compounds with roles in multiple cellular functions including cell death and can
include superoxide (O2-) and hydrogen peroxide (H2O2) (47). Routine cellular
activities, such as aerobic respiration, can result in the production of ROS.
Further, nitric oxide synthase (NOS) can contribute as an endogenous source of
ROS under conditions of reduced availability of tetrahydrobiopterin or L-arginine
and ultimately generates OH• and NO2• (47), (4). Hypoxic conditions additionally
serve as a cause of mitochondrial production of ROS (47). ROS maintain the
ability to both stimulate and inhibit cell death (47), (4).

Aerobic Respiration and ROS Production
Mitochondria house an electron transport chain (ETC) which coincides with its
purpose of serving as the major source of energy for cells. Remarkably, it is the
ETC which also provides the major source of ROS in mammalian cells (4), (51).
Electron “leak” in pairs from electron carriers forms H2O2 and a single electron
leak forms superoxide (60). Complex III (cytochrome C oxidoreductase) and
complex IV (cytochrome C oxidase) are the sites of superoxide production in the
ETC (51), (60). Although mitochondrial respiration is the major source of ROS,
the amount produced is not sufficient to cause devastating effects on the cell in
non-disease states.
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Hypoxia and ROS Production via Mitochondria
Mitochondrial production of ROS functions in normal cell signaling when
generated at low concentrations (27). However, a deficiency in oxygen available
to cells is suggested to result in mitochondrial ROS production by complexes I
and III (27), (59), (74). Superoxide appears to be the primary ROS generated by
complex III under hypoxic conditions and ROS from complex III are thought to
activate hypoxia-inducible factor-1α (HIF-1α) (27), (74). HIF-1 plays a protective
role for cells experiencing hypoxic conditions and is known to execute a number
of functions in response to low oxygen levels in attempts to maintain cell survival
(10). However, Shvetsova et al. have provided evidence which shows that HIF1α activation is dependent on the proper functioning of mitochondria (74).

ROS and Apoptosis
Production of ROS, if not equally countered by their catabolism, can result in
accumulation which leads to oxidative stress (47). This excessive quantity of
ROS can react with biomolecules to cause cellular and DNA damage resulting in
cell death. Evidence exists to support the role of hydrogen peroxide (H2O2)
contributing to oxidative stress and ultimately signaling apoptosis through the
intrinsic pathway (51), (39). Liu et al. have shown that H2O2 can induce cellular
morphological defects, oxidative stress, increased levels of Bax, disruption of
ΔΨm and apoptosis (39). Additionally, Bcl-2 is known to be involved in inhibition
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of cell death through apoptosis (7). Kern et al. have provided evidence for the
role of Bcl-2 in prevention of endothelial superoxide (O2-) production in a murine
model of Bcl-2 overexpression (32). Further, support exists for a reduction in
apoptosis in a model of mitochondrial superoxide dismutase (SOD2) expression
by adenovirus transfection (7). Together, the present evidence suggests that
oxidative stress, attributable to H2O2 and O2-, bring about apoptosis through the
mitochondrial-mediated pathway.
Mechanisms do exist to regulate the production of ROS. For example, the
availability of necessary cofactors, receptor activation and cell signaling
cascades which result in ROS production can be controlled (47). Furthermore,
enzymes exist to neutralize harmful oxygen free radicals. Superoxide dismutase
(SOD) functions to convert O2- into H2O2 which can be further broken down into
water and oxygen by the enzyme catalase. Mn-dependent SOD (SOD2) exists in
the mitochondrial matrix and functions to protect mitochondria from the effects of
O2-. However, few researchers have observed SOD2 decrease in response to
oxidative stress induced by H2O2 (39).
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Nitric Oxide (NO) and Apoptosis
Infection and the Immune Response
Invasion by foreign microbes or toxins elicit standard responses by the
immune system which are categorized as innate and adaptive. Adaptive
immunity includes specific T-cell and B-cell responses which require more time to
occur and last for longer periods compared to innate immune responses (48).
Innate immunity involves an initial swift response to invading pathogens and
toxins due to recognition of foreign molecular structures (48). Release of
inflammatory mediators is a well-established innate immune reaction (48), (50).
Macrophages, derived from monocyte differentiation, function in the innate
immune response to eliminate invading microbes through nitric oxide (NO)
release and oxidative damage (48). Apoptosis can occur because of infection by
many bacterial species despite efforts by the immune system to control and
eliminate pathogens (50). Bacterial toxins, such as lipopolysaccharide (LPS)
derived from gram negative species, are also known elicit inflammation due to its
recognition by Toll-like receptor 4 (TLR4) (12). Pro-inflammatory factors, such as
tumor necrosis factor alpha (TNF-α), interferon-gamma (IFN-γ), interleukin-6 (IL6) and LPS can lead to the generation of NO by inducible nitric oxide synthase
(iNOS) (61). Macrophage release of NO in response to LPS has been wellcharacterized as well as the cytotoxicity of high exogenous NO levels (46), (62).
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Role of NO in the induction of apoptosis
There exist three enzymatic sources of NO production by nitric oxide
synthases including neuronal (nNOS), endothelial (eNOS) and inducible (iNOS)
(61), (62). NO production by nNOS and eNOS from L-arginine remains a
physiological necessity, however, iNOS production of NO is known to occur
under inflammatory conditions (61), (62). In addition to its role in maintaining
normal physiological functions, NO is involved in inducing mitochondria-mediated
cell death (13). Snyder et al. has provided experimental data implicating that NO
induces the formation and subsequent insertion of Bax/Bak oligomers into the
outer mitochondrial membrane to result in cytochrome C release and apoptosis
(61).

Endotoxemia or Sepsis and Apoptosis
Sepsis and Apoptosis
Sepsis occurs as the result of a widespread inflammatory reaction to infection.
This condition consists of two stages: hyperdynamic and hypodynamic, also
referred to as the warm and cold stages of sepsis, respectively. The initial
hyperdynamic stage involves warm and perfused extremities due to high cardiac
output and low peripheral resistance of blood vessels. However, the
cardiovascular system is unable to maintain this perfused stage which can lead
to a decline to the hypodynamic stage (15), (55). When this occurs, organ
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perfusion is dramatically reduced. A patient in this stage of sepsis will experience
cold extremities due to the effects of inflammation on vascular permeability and
subsequent lack of perfusion.
Data from Chopra et al. has provided evidence to show that adult rat
ventricular myocytes (ARVMs) undergo apoptosis (14). The evidence implicates
the involvement of the intrinsic pathway of apoptosis due to the increased levels
of Bax and cytochrome C as well as morphological changes in mitochondria such
as swelling and membrane deformity (46),(68). Further, progression to apoptosis
in sepsis has been well-documented in the pathophysiology of sepsis (13), (67).

Endotoxemia and Apoptosis
Endotoxemia is defined as the presence of endotoxins in the blood, for
example, lipopolysaccharide (LPS) derived from the outer membranes of gramnegative bacteria. Consequences of endotoxemia include metabolic endotoxemia
defined as endotoxins in the blood derived from intestinal bacteria, the
development of inflammation, shock, or death (37), (20). The induction of
endotoxemia under experimental conditions can be utilized as a model system
for studying pharmacological interventions for septic patients (31). According to
Kamisoglu et al., the pathophysiology of sepsis and endotoxemia share similar
metabolic profiles and the metabolic distinctions between endotoxemia and
sepsis increase with time (31). These findings suggest that pharmacological
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treatments evaluated during experimental endotoxemia should be administered
as early as possible during the onset and progression of sepsis in patients.
Present data also provides evidence for the ability of LPS to induce apoptosis
in hepatocytes at 1000 ng/mL (49). In addition to cell death, LPS has been
observed to produce dissipated ΔΨm, reduced levels of ATP and mitochondrial
cytochrome C (49). Moreover, Wang et al. have demonstrated the capacity for
LPS to induce apoptosis and caspase-3 activity in adult rat ventricular myocyte
(ARVM) at concentrations as low as 10 ng/mL (66). Further, this study also
demonstrated a greatly enhanced effect of LPS on disrupted ΔΨm, mitochondrial
Bax translocation and cytochrome C release in combination with β1-adrenergic
receptor activation in cardiomyocytes (66). Together, these experimental data
support the capacity for LPS-induced endotoxemia to cause mitochondrial
dysfunction and activation of the intrinsic apoptosis cascade - effects which can
be augmented by β-adrenergic stimulation and affect multiple cell types.
However, the degree of these effects appears to vary with LPS concentration.

MitoKATP Channels and Apoptosis
Potassium ATP (KATP) channel structure consists of 4 subunits each of Kir and
SUR proteins. The aqueous pore through which potassium ions flow out of the
cell is formed by the Kir subunits. The SUR subunits exhibit pharmacological
functions in that they contain binding sites for various agents which affect ion flow
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through the channel. Ion transport through these channels can be regulated by
varying ATP and nucleotide diphosphate concentrations. During the physiological
state, mitoKATP channels function to transport potassium ions into the matrix to
maintain volume. Low levels of ATP can activate the flow of potassium ions
through these channels and increased flow of potassium out of the cell leads to
hyperpolarization of the cell membrane. In mitochondria, the opening of these
channels leads to depolarization of the mitochondrial membrane (68).
Matrix Volume and Cytochrome C Release
Mitochondrial swelling due to increased matrix volume has been shown to
result in cytochrome C release without the need for increased mitochondrial
membrane permeability (28). Evidence also exists to suggest that mitochondrial
swelling due to K+ influx through mitoKATP channels can rupture the OMM and
permit cytochrome C release (18). Moreover, recent data has shown that
valinomycin, an ionophore specific to K+, can induce mitochondrial swelling and
release of cytochrome C (41). Consequently, blockage of mitoKATP channels by
5HD, a mitoKATP channel blocker, may reduce matrix swelling and cytochrome C
release, thereby reducing the extent of cell death under the intrinsic pathway of
apoptosis.
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MitoKATP Channels and Mitochondrial Membrane Potential (ΔΨm)
Dissipation of mitochondrial membrane potential (ΔΨm) has been considered
an early event in apoptosis and also necessary for cytochrome C release (63).
Likewise, collapse of ΔΨm is linked to the progression of cell death and is a
conventional parameter used for detection and measurement of apoptosis (63).
Reduced mitochondrial membrane potential is a known result of mitoK ATP
channel opening (42). Accordingly, prevention of mitoKATP channel activity may
limit the degree of ΔΨm disruption and reduce the magnitude of cell death.

Reactive Oxygen Species
MitoKATP channel opening has been found to lead to increases in
mitochondrial generation of ROS, particularly superoxide and hydrogen peroxide
(18), (42), (70). This effect has also been proposed as a mechanism of
cardioprotection from prolonged ischemic damage through ROS signaling
pathways - an effect which can be induced by the mitoKATP channel opener
diazoxide and inhibited by 5-HD (18), (70). However, the effects of ROS signaling
are concentration-dependent and oxidative stress is known to cause cell death
involving the intrinsic apoptosis pathway (17). Consequently, it can be suggested
that under the conditions of sepsis or endotoxemia, mitoKATP channel opening
may be detrimental to the survival of patients experiencing myocardial
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dysfunction. Rather, blockage of these channels may prove more beneficial to
the condition as a method of preserving cardiomyocyte function.
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AIMS AND OBJECTIVES
Vascular dysfunction, end-organ failure and high mortality rates are
associated with endotoxemia, sepsis and septic shock. Recently, focus has been
on mitochondrial ultrastructural changes and function due to sepsis and sepsisrelated pathologies. Data from Sharma’s laboratory indicated involvement of
mitochondrial-mediated intrinsic apoptosis cascade in regulating ARVM
dysfunction in sepsis. Experimental endotoxemia has shown mitochondrial
membrane potential collapse, membrane permeability changes and release of
cytochrome C as indicators of mitochondrial dysfunction. Outer mitochondrial
membrane (OMM) permeability is controlled by Bax translocation, resulting
Voltage Dependent Anion Channels (VDACs) pores in the OMM and activation of
mitoKATP channels in the inner mitochondrial membrane. Endotoxins can induce
mitochondrial damage and there is a correlation between the severity of sepsis
and mitochondrial damage and dysfunction. The data from our laboratory
indicate that 5HD treatment that blocks mitoKATP channels could increase
survival in septic rats and increase contractility in septic cardiomyocytes. He
progression of sepsis is known to involve vascular dysfunction. Therefore, we
hypothesize that inhibition of mitoKATP channels by 5HD restores altered
mitochondrial membrane permeability in human umbilical vein endothelial cells
due to LPS-induced endotoxemia. To investigate this hypothesis the following
specific aims are developed.
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Specific Aim 1. To determine time-dependent and dose-dependent effects
of LPS and 5HD on mitochondrial dysfunction in HUVECs
Prior to testing the restorative properties of 5HD (5-hydroxydecanoic acid) on
mitochondrial membranes in endotoxic human umbilical vein endothelial cells
(HUVEC), it is necessary to determine the time- and dose-dependent effects of
5HD and lipopolysaccharide (LPS) on HUVEC viability. Cell viability assays have
been conducted using Presto blue dye to measure metabolic activity of the cells
following treatment with LPS and 5HD at increasing concentrations.

Specific Aim 2. To determine if 5HD modulates LPS-induced a)
mitochondrial dysfunction b) NO and catalase levels and c) proapoptotic
markers such as Bax, Cytochrome C and Apaf-1 in HUVECs
The effect of 5HD on LPS-induced alterations of mitochondrial membrane
potential (measure of mitochondrial membrane integrity) in HUVECs can be
determined. Macrophages serve as a positive control as the ability of LPS to
decrease viability of these cells has been well characterized. Mitochondrial
membrane potential will be assessed using JC-1 cationic dye. NO and catalase
levels were measured by colorimetric assay and levels of proapoptotic proteins
were measured using immunoblot procedures.
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Materials and Methods
Chemical Preparations
Chemical compounds were purchased from Sigma-Aldrich (St. Louis, MO)
and prepared in sterile deionized water. Treatments were prepared in warm
Medium 200 (GibcoTM; Thermo Fisher Scientific, Grand Island, NY) at the
required concentrations. All drugs and treatments were prepared under sterile
conditions and vortexed prior to usage.
5-Hydroxydecanoic Acid (5HD)
5-hydroxydecanoic acid sodium salt (MW; 210.25 g/mol) was prepared at a
100,000 μM stock concentration. The 100,000 μM stock was further diluted to a
working concentration of 1000 μM in sterile deionized water. 1000 μM
concentration aliquots were prepared and stored at -80oC for future use.
Lipopolysaccharide (LPS)
Lipopolysaccharide was prepared at a 100,000 ng/mL stock concentration.
The 100,000 ng/mL stock was further serially diluted to 10,000 ng/mL and then to
a working concentration of 1000 ng/mL in sterile deionized water. 1000 ng/mL
concentration aliquots were prepared and stored at -80oC for future use.
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Cell Culture
Human umbilical vein endothelial cells (HUVEC) were purchased from ATCC
(Manassas, VA) and cultured in Medium 200 supplemented with low serum
growth supplement (LSGS) (GibcoTM; Thermo Fisher Scientific, Grand Island,
NY) containing 10 µg/mL heparin, 1 µg/mL hydrocortisone, 10 ng/mL human
epidermal growth factor, 3 ng/mL basic fibroblast growth factor, 2% FBS and 1%
penicillin and streptomycin (46). Cells were incubated at 37oC, 5% CO2 and 80%
humidity. Medium was exchanged every other day and cells were passaged at
95% confluency in trypsin plus 0.25% EDTA. Cells were cultured and maintained
in T175 cell culture flasks and treated at 75-80% confluency for cytotoxicity
assays and 90-95% confluency for all other assays.
Treatment
Cells were passaged with trypsin plus 0.25% EDTA, counted using the trypan
blue cell counting method and cell suspension was plated on cell culture plates at
volumes and seeding densities based on specifications necessary for each
experiment. Treatments were prepared based on cell culture plate well volume
and concentration of drug required per well from 1000 μM or 1000 ng/mL working
concentrations. A master mix was prepared and calculated for based on the
number of plated wells to be treated and the volume of each well. All drugs were
prepared in Medium 200 warmed in a 37oC water bath and under sterile
conditions, vortexed and mixed during treatment preparation as well as prior to
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addition to cells. HUVEC model of endotoxemia was induced by treatment of
cells with LPS 100 ng/mL.
Determination of Cell Viability
HUVECs were cultured on 48-well plates and seeded at a density of 70,000
cells per well. The cells were treated with LPS for 16 and 24 hours with the
following dosages: 50 ng/mL, 100 ng/mL, 500 ng/mL, 1000 ng/mL, 5000 ng/mL
and LPS 100 ng/mL plus 5HD 50 µM. Cells were treated with 5HD at the
following dosages: 50 µM, 100 µM, 200 µM and 500 µM. Cells were treated at
75-80% confluency. Cells were incubated for 1 hour with PrestoblueTM Cell
Viability Reagent (Molecular Probes; Invitrogen, Carlsbad, CA) and absorbance
was measured using Biotek Synergy HT microplate reader. Cell viability was
quantified based on absorbance of metabolically active cells at 570 nM.

Determination of Mitochondrial Membrane Potential
JC-1 Fluorescent Imaging (13)
JC-1 assay kit was purchased from Molecular Probes (Life Technologies;
Thermo Fisher, Grand Island, NY). Performance of the JC-1 cationic dye assay
was adapted from vendor directions. HUVECs were cultured and plated on 48well plates at 60,000 cells per well and treated at 90% confluency with the
following treatment groups: LPS 100 ng/mL, 5HD 50 µM and LPS plus 5HD.
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Assays were performed at 2, 4, 6, 16 and 24 hours. Carbonyl cyanide 3chlorophenylhydrazone (CCCP), a mitochondrial membrane depolarizer, was
added 5 minutes prior to addition of JC-1 dye at a final concentration of 50 μM as
per vendor guidelines to serve as a positive control for JC-1 fluorescence activity.
Treatment groups and positive controls were incubated with 5 µL of 200 µM JC-1
cationic dye for 30 minutes and washed with 10X PBS. Cells were imaged using
EVOS FL Cell Imaging System (Thermo Fisher Scientific, Grand Island, NY) at
20X magnification.

Immunoblot Analysis (13)
HUVECs were seeded at a density of 2x106 cells per well on 6-well cell
culture plates and treated with LPS 100 ng/mL, 5HD 50 μM and LPS plus 5HD
for 16 hours. Cells were lysed with 100 μL RIPA buffer and incubated on ice for 5
minutes. The collected lysate remained on ice for 10 minutes prior to
centrifugation at 13.3g and 4oC for 10 minutes. Protein quantification of collected
lysate was performed using PierceTM BCA Protein Assay Kit (Thermo Fisher,
USA) according to vendor directions. 40 μg of protein sample was loaded into
each sample well of gel. Gels were run at 150V for 1 hour prior to transfer to
PVDF membrane. Membranes were incubated with primary antibody overnight at
4oC on a rocker and secondary antibody for 45 minutes at room temperature on a
rocker. Primary antibody was prepared in 5 mL Odyssey® Blocking Buffer (PBS)
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(Li-COR, USA), 5 μL Tween 20 and 1 μL mouse monoclonal β-actin antibody
(Santa Cruz). All primary antibodies were prepared at a 1:1000 concentration.
Membranes were imaged using Li-COR Odyssey® CLx Imaging System
(Lincoln, NE) for 7 minutes exposure time per membrane. Bands were quantified
using Li-COR Image StudioTM Lite (Lincoln, NE). All samples were run in triplicate
(N = 3).
Apoptotic Protease Activating Factor 1 (Apaf1)
Samples were run on 10-well 7.5% SDS gels prepared according to directions
adapted from Northern Arizona University Lab Protocols. Rabbit polyclonal antiApaf1 antibody was purchased from Abcam (Cambridge, MA). PVDF
membranes were incubated with 1 μL anti-rabbit and 1 μL anti-mouse secondary
antibodies.
Cytochrome C and Bax
Samples were run on 10-well 4-20% gels purchased from Bio-Rad (Hercules,
CA). Sheep polyclonal anti-Cytochrome C and rabbit monoclonal anti-Bax
antibodies were purchased from Abcam (Cambridge, MA). PVDF membranes for
Bax quantification was incubated with 1 μL anti-mouse plus 1 μL anti-rabbit.
PVDF membranes for Cytochrome C quantification were incubated with 1 μL
anti-sheep purchased from Abcam (Cambridge, MA) and 1 μL anti-mouse
secondary antibodies.
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Assays
Enzyme-Linked Immunosorbent Assays
Catalase
HUVECs were seeded at a density of 2x106 cells per well on 6-well cell
culture plates and treated with LPS 100 ng/mL, 5HD 50 μM and LPS plus 5HD
for 16 hours. Following treatment, cells were lysed and protein was extracted for
catalase quantification using Abcam Human Catalase ELISA Kit (Cambridge,
MA) adapted from manufacturer directions. HUVEC lysate was centrifuged at
13.3 g for 20 minutes at 4oC and the collected supernatant was immediately
assayed. Samples were incubated with capture and detection antibody cocktail
out of direct light and at room temperature for 1 hour and 15 minutes on a plate
shaker at 150 rpm. Optical density (OD) was recorded at 450 nM using Biotek
Synergy HT microplate reader. Samples were assayed as three sets for each
treatment group and run in duplicates (N = 6).
Griess Reagent Assay (56)
HUVECs supernatant was collected from prior treatments with LPS 100
ng/mL, 5HD 50 μM and LPS plus 5HD for 2, 4, 6, 16 and 24 hours and used for
quantification of nitrite release using Promega Griess Reagent System (Madison,
WI). Samples were run in three sets in duplicates (N = 6) on a 96-well plate
according to manufacturer protocol. Samples were incubated for 10 minutes at
room temperature and out of direct light with sulfanilamide. Samples were then
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incubated for 10 minutes at room temperature and out of direct light with N-1napthylethylenediamine dihydrochloride (NED). Absorbance was measured at
520 nM using Biotek Synergy HT microplate reader.
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Results
Effect of LPS (50, 100 and 1000 ng/mL) on HUVEC viability
The effect of LPS at increasing concentrations, i.e., 50, 100 and 1000
ng/mL was observed in HUVEC. With increasing concentration, a decrease in
HUVEC viability was observed in cells treated with LPS 50 ng/mL, 100 ng/mL
and 1000 ng/mL for both 16 (Fig. 1) and 24 (Fig. 2) hours. This suggests that
LPS deceases cell viability in dose-dependent and time-dependent manner.
Effect of 5HD on HUVEC viability
5HD, a putative mitoKATP blocker, produces a decrease in viability in
HUVEC treated with 5HD 50 μM, 100 μM and 200 μM for 24 hours. Significant
reductions in HUVEC viability were observed at the aforementioned
concentrations with the higher concentrations of 100 and 200 μM producing
similar significant reductions in cell viability. This data suggests that 5HD reduces
HUVEC viability at increasing concentrations of the compound (Fig. 3).
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Figure 1: Dose-dependent effect of LPS (50, 100 and 1000 ng/mL) on human umbilical
vein endothelial cell (HUVEC) viability at 16 hours. The dose-dependent effects of LPS 50
ng/mL and 100 ng/mL on HUVEC viability at 16 hours.
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Figure 2: Dose-dependent effect of LPS (50, 100 and 1000 ng/mL) on human umbilical
vein endothelial cell (HUVEC) viability at 24 hours. The dose-dependent effects of LPS 50
ng/mL and LPS 100 ng/mL on HUVEC viability at 24 hours.
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Figure 3: Dose-dependent effect of 5-hydroxydecanoic acid (5HD) on human umbilical
vein endothelial cell (HUVEC) viability at 24 hours. The dose-dependent effects of 5HD at
50 μM, 100 μM and 200 μM on HUVEC viability at 24 hours. Statistical significance was
determined through one-way analysis of variance (ANOVA). P < 0.0001
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Effect of 5HD on LPS-induced effect on nitrite levels
The time-dependent effect of 5HD on LPS-induced effects on nitrite
release was measured in HUVEC treated at 2, 4, 6, 16 and 24 hours. HUVEC
treated with LPS alone showed significant increases in nitrite release following
treatment for 16 and 24 hours. 5HD (50 μM) in the presence of LPS at 100 ng/mL
did not affect the LPS-induced elevated levels of nitrite at both 16 and 24-hour.
This suggests that 5HD does not diminish the LPS-induced nitrite release in
HUVEC (Fig. 4).
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Figure 4. Effects of LPS, 5HD and LPS + 5HD on nitrite release in HUVEC. The effects of
LPS 100 ng/mL, 5HD 50 μM, and LPS + 5HD nitrite release in HUVECs treated for 2, 4, 6, 16
and 24 hours. Statistical significance was determined through one-way analysis of variance
(ANOVA). P < 0.0001
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The Effect of 5HD on LPS-induced effect on cytosolic Bax, Cytochrome C
and Apaf-1 proteins
The effect of 5HD (50 µM) in the presence and absence of LPS (100
ng/mL) was observed using Western blot at 16 hours post treatment. LPS did not
significantly alter protein levels of cytosolic Bax and Cytochrome C. Also, 5HD
did not alter the effect of LPS on Bax and Cytochrome C levels (Fig. 5 and Fig 6,
respectively).
LPS produces a significant decrease in the levels of Apaf-1 (Fig. 7).
Treatment with 5HD significantly reduced levels of Apaf-1 compared to control
(alone group).
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Figure 5. Effect of 5HD on the LPS-induced response on Bax. Effect of LPS 100 ng/mL,
5HD 50 μM and LPS + 5HD on the levels of Bax protein in HUVEC treated for 16 hours.
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Figure 6. Effect of 5HD on the LPS-induced response on Cytochrome C. Effect of LPS 100
ng/mL, 5HD 50 μM and LPS + 5HD on the levels of Cytochrome C protein in HUVEC treated for
16 hours.
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Figure 7. Effect of 5HD on the LPS-induced response on protein levels of Apaf1. Effect of
LPS 100 ng/mL, 5HD 50 μM and LPS + 5HD on the levels of Apaf1 protein in HUVEC treated
for 16 hours. Statistical significance was determined through one-way analysis of variance
(ANOVA). *P < 0.0197, **P < 0.0175, P < 0.0001
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Effect of 5HD on LPS-induced mitochondrial membrane potential
alterations in HUVEC
The effect of 5HD on mitochondrial membrane integrity in LPS-treated
HUVEC was visualized at 16 and 24 hours by JC-1 assay. Mitochondrial
membrane disruption is evident as green fluorescence in LPS treatment groups
at both 16 and 24 hours indicating the presence of cytoplasmic JC-1 monomers
(Fig. 8 and 9).

Figure 8. Effect of LPS, 5HD and LPS + 5HD on mitochondrial membrane potential (∆Ψm) in
HUVEC. The effect of LPS 100 ng/mL, 5HD 50 μM and LPS + 5HD on mitochondrial membrane
potential in HUVECs treated for 16 hours.
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Figure 9. Effect of LPS, 5HD and LPS + 5HD on mitochondrial membrane potential (∆Ψm) in
HUVEC. The effect of LPS 100 ng/mL, 5HD 50 μM and LPS + 5HD on mitochondrial membrane
potential in HUVECs treated for 24 hours.
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The effect of 5HD on LPS-induced increase in cytosolic catalase
LPS-induced endotoxemia is known to lead to the production of reactive
oxygen species and ultimately oxidative stress (27). To determine whether 5HD
plays a role in protection from oxidative damage in endotoxic HUVEC, catalase
levels were quantified through ELISA following 16-hour treatment. LPS-treated
HUVEC showed a significant increase in catalase expression. A high level of
catalase in response to LPS was blocked by co-treatment with 5HD (Fig. 10)
suggesting that 5HD offers endotoxic cells protection from the generation of
reactive oxygen species.

Figure 10. Effect of 5HD on LPS-induced increase in Catalase. The effect of 5HD 50 μM on the
LPS-induced increase in catalase protein expression in HUVECs treated for 16 hours. Statistical
significance was determined through one-way analysis of variance (ANOVA). P < 0.0001

43

DISCUSSION
Sepsis, septic shock and endotoxemia have been shown to produce
vascular perfusion dysfunction in experimental models (1, 52, 53, 57). Likewise,
in the current in vitro model of endotoxemia in HUVEC, a 25 and 30% decrease
in cell viability after 16 and 24 hours post LPS treatment was observed.
Additionally, a 51% decrease after 24-hour treatment with LPS 1000 ng/mL was
observed suggesting a time- and dose-dependent decrease in cell viability in
HUVECs. Similar data has been reported by other investigators (46, 58).
It is well-established that LPS activates the toll-like receptor 4 (TLR-4)
signaling pathway (26), (16). The TLR-4 pathway ultimately activates NF-κB
nuclear translocation which can go on to induce the transcription of proinflammatory molecules and iNOS (26). Choy et al. have recently demonstrated
that LPS acts through the TLR-4 pathway to induce apoptosis in HUVEC as well
as increases inducible nitric oxide synthase (iNOS) levels (16). Additionally,
nitrite can be used to generate nitric oxide (NO) and can, therefore, also be used
to indirectly quantify levels of NO production (35). Experimental evidence shows
that LPS treatment increases nitrite levels in HUVEC in a time-dependent
manner. However, it appears that 5HD does not diminish the LPS-induced nitrite
release in HUVEC. These data suggest that the protective effects of 5HD likely
occur downstream of initial inflammatory events in response to LPS.
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LPS-induced endotoxemia is known to lead to the production of reactive
oxygen species and ultimately oxidative stress (61). MitoKATP channel opening is
also known to lead to the production of ROS, an effect which can be opposed by
blockage of the channel by 5HD (18). Prevention of mitoKATP channel activity by
5HD could reduce the generation of ROS from mitoKATP channels and therefore
suppress the need for antioxidant enzyme expression. Data show that LPS
treatment increases catalase levels. Low levels of ROS are known to be typically
generated as a result of oxidative phosphorylation which may be involved in the
catalase levels observed in the control group. 5HD treatment alone resulted in
catalase levels similar to the control group suggesting that the protective effects
of 5HD are limited to HUVEC in endotoxemia rather than healthy cells. However,
treatment of HUVEC with LPS induced an increase in the levels of H2O2 as
indicated by the greater catalase levels. In contrast, 5HD reduced this LPSinduced increase in catalase expression. These results suggest that 5HD may
offer protection to endotoxic cells from oxidative damage by preventing the
generation of excessive H2O2 thereby reducing the need for catalase activity.
Since, in the current study, 5HD did not alter LPS-induced elevated NO levels, it
appears the free radical scavenging effect could by mediated through cytosolic
catalase and may have no or negligible effects from superoxide dismutase.
Further studies are needed to establish this stipulation.
LPS has been shown to induce cell death directly in several in vitro
models such as bovine endothelial cells and HUVECs (45),(29). Shioiri et al.,
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(2009) reported that LPS causes activation of caspse-3 and 7, decreases cell
viability and produces cytotoxicity. In the current study, we observed that LPS
failed to produce an increase in cytosolic- Bax and cytochrome C levels. This
result is most likely due to the fact that LPS causes activation of caspse-3 which
rapidly releases to the supernatant (58). In addition, cytochrome C is released
from the intermembrane space rather than expressed and Bax exists primarily in
the cytosol prior to mitochondrial relocation and oligomerization following an
apoptotic stimulus (21), (72). Moreover, 5HD reduces Apaf-1 expression due to
LPS-induced endotoxemia in HUVEC. These data suggest that 5HD treatment
can prevent Apaf-1 expression above normal baseline levels in endotoxic
HUVEC which may prevent apoptosome formation. However more studies are
warranted to confirm this speculation.
To elucidate the role of the intrinsic apoptotic cascade mediated via
mitochondria, we also studied role of 5HD in mitochondrial membrane potential
alterations, an indicator for mitochondrial integrity, during endotoxemia in
HUVECs. Preservation of mitochondrial membrane potential (∆Ψm) requires
intact mitochondrial membranes. Mitochondrial membrane permeabilization due
to Bax insertion and pore formation which facilitates cytochrome C release is
known to occur under the intrinsic pathway (24). Pore formation can impede
oxidative phosphorlation and the resulting ATP depletion may activate mitoKATP
channels. MitoKATP channel opening leads to influx of potassium ions, matrix
swelling and depolarization which are known to occur in apoptosis. The increase
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in matrix volume due to this channel opening has also been shown to disrupt
outer mitochondrial membrane integrity and contribute to cytochrome C release
(28), (18). 5HD appears to alleviate the LPS-induced mitochondrial membrane
potential alterations in endotoxic HUVEC at both 16 and 24 hours. HUVEC
treated with 5HD alone for 16 hours exhibited more red than green fluorescence
compared to 24-hour treatment which shows substantially more green than red.
This abundance of cytoplasmic JC-1 monomers at 24 hours suggests that
prolonged exposure to 5HD may disrupt ∆Ψm in healthy HUVEC. Greater red
fluorescence is noticeable following LPS and 5HD co-treatment which indicates
more JC-1 aggregates within mitochondria with intact ∆Ψm compared to LPS
alone at 16 and 24 hours. Considerable green color is not obvious in LPS group
at 16 hours compared to 24 hours indicating that LPS in a time-dependent
manner produced the degree of ∆Ψm, an effect which was reversed by inhibition
of mitoKATP channels. The data supports our earlier obvervation in ARVM, where
5HD, a mitoKATP channel blocker, increased viability of septic cardomyocytes
and survival of septic animals (13).
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CONCLUSIONS
The current study provides evidence for the role of 5HD, a putative
mitoKATP blocker, in preserving ∆Ψm in endotoxic cells. 5HD may exert a
protective effect on endotoxic HUVEC by reducing the magnitude of cell death as
this compound appears to play a role in preventing Apaf-1 expression and
maintaining ∆Ψm in endotoxic HUVEC which may reduce cytochrome C release.
Further protection from cell death arises from the ability of 5HD to reduce H 2O2
generation in endotoxic HUVEC.

48

REFERENCES
1.

Alden KJ, Motew SJ, Sharma AC, and Ferguson JL. Effect of

aminoguanidine on plasma nitric oxide by-products and blood flow during chronic
peritoneal sepsis. Shock 9: 289-295, 1998.
2.

Anderson EJ, Katunga LA, and Willis MS. Mitochondria as a source

and target of lipid peroxidation products in healthy and diseased heart. Clin Exp
Pharmacol Physiol 39: 179-193, 2012.
3.

Baines CP. The molecular composition of the mitochondrial permeability

transition pore. J Mol Cell Cardiol 46: 850-857, 2009.
4.

Bhattacharyya A, Chattopadhyay R, Mitra S, and Crowe SE. Oxidative

stress: an essential factor in the pathogenesis of gastrointestinal mucosal
diseases. Physiol Rev 94: 329-354, 2014.
5.

Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi

A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, and Pinton P.
ATP synthesis and storage. Purinergic Signal 8: 343-357, 2012.
6.

Bournat JC, and Brown CW. Mitochondrial dysfunction in obesity. Curr

Opin Endocrinol Diabetes Obes 17: 446-452, 2010.
7.

Brand MD. Mitochondrial generation of superoxide and hydrogen

peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med
100: 14-31, 2016.

49
8.

Brenner C, Subramaniam K, Pertuiset C, and Pervaiz S. Adenine

nucleotide translocase family: four isoforms for apoptosis modulation in cancer.
Oncogene 30: 883-895, 2011.
9.

Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, and

Boise LH. Caspase-9, caspase-3 and caspase-7 have distinct roles during
intrinsic apoptosis. BMC Cell Biol 14: 32, 2013.
10.

Chaplin DD. Overview of the immune response. J Allergy Clin Immunol

125: S3-23, 2010.
11.

Chen CH, Ferreira JC, Gross ER, and Mochly-Rosen D. Targeting

aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94: 1-34,
2014.
12.

Chi DS, Qui M, Krishnaswamy G, Li C, and Stone W. Regulation of

nitric oxide production from macrophages by lipopolysaccharide and
catecholamines. Nitric Oxide 8: 127-132, 2003.
13.

Chopra M, Golden HB, Mullapudi S, Dowhan W, Dostal DE, and

Sharma AC. Modulation of myocardial mitochondrial mechanisms during severe
polymicrobial sepsis in the rat. PLoS One 6: e21285, 2011.
14.

Chopra M, and Sharma AC. Contractile response of norepinephrine is

modulated by caspase-3 in adult rat ventricular myocytes isolated from septic rat
heart. Pharmacol Res 60: 303-313, 2009.
15.

Chopra M, and Sharma AC. Distinct cardiodynamic and molecular

characteristics during early and late stages of sepsis-induced myocardial
dysfunction. Life Sci 81: 306-316, 2007.

50
16.

Choy KW, Lau YS, Murugan D, Vanhoutte PM, and Mustafa MR.

Paeonol Attenuates LPS-Induced Endothelial Dysfunction and Apoptosis by
Inhibiting BMP4 and TLR4 Signaling Simultaneously but Independently. J
Pharmacol Exp Ther 364: 420-432, 2018.
17.

Circu ML, and Aw TY. Reactive oxygen species, cellular redox systems,

and apoptosis. Free Radic Biol Med 48: 749-762, 2010.
18.

Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, and Garlid

KD. The direct physiological effects of mitoK(ATP) opening on heart
mitochondria. Am J Physiol Heart Circ Physiol 290: H406-415, 2006.
19.

D'Souza Y, Elharram A, Soon-Shiong R, Andrew RD, and Bennett BM.

Characterization of Aldh2 (-/-) mice as an age-related model of cognitive
impairment and Alzheimer's disease. Mol Brain 8: 27, 2015.
20.

de Punder K, and Pruimboom L. Stress induces endotoxemia and low-

grade inflammation by increasing barrier permeability. Front Immunol 6: 223,
2015.
21.

Dewson G, and Kluck RM. Mechanisms by which Bak and Bax

permeabilise mitochondria during apoptosis. J Cell Sci 122: 2801-2808, 2009.
22.

Doenst T, Nguyen TD, and Abel ED. Cardiac metabolism in heart failure:

implications beyond ATP production. Circ Res 113: 709-724, 2013.
23.

Falschlehner C, Schaefer U, and Walczak H. Following TRAIL's path in

the immune system. Immunology 127: 145-154, 2009.

51
24.

Flores-Romero H, Garcia-Porras M, and Basanez G. Membrane

insertion of the BAX core, but not latch domain, drives apoptotic pore formation.
Sci Rep 7: 16259, 2017.
25.

Galloway CA, and Yoon Y. Mitochondrial dynamics in diabetic

cardiomyopathy. Antioxid Redox Signal 22: 1545-1562, 2015.
26.

Garcia Bueno B, Caso JR, Madrigal JL, and Leza JC. Innate immune

receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci
Biobehav Rev 64: 134-147, 2016.
27.

Gillespie MN, Al-Mehdi AB, and McMurtry IF. Mitochondria in hypoxic

pulmonary vasoconstriction: potential importance of compartmentalized reactive
oxygen species signaling. Am J Respir Crit Care Med 187: 338-340, 2013.
28.

Gogvadze V, Robertson JD, Enoksson M, Zhivotovsky B, and

Orrenius S. Mitochondrial cytochrome c release may occur by volumedependent mechanisms not involving permeability transition. Biochem J 378:
213-217, 2004.
29.

Hu X, Yee E, Harlan JM, Wong F, and Karsan A. Lipopolysaccharide

induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial
cells. Blood 92: 2759-2765, 1998.
30.

Julien O, and Wells JA. Caspases and their substrates. Cell Death Differ

24: 1380-1389, 2017.
31.

Kamisoglu K, Haimovich B, Calvano SE, Coyle SM, Corbett SA,

Langley RJ, Kingsmore SF, and Androulakis IP. Human metabolic response

52
to systemic inflammation: assessment of the concordance between experimental
endotoxemia and clinical cases of sepsis/SIRS. Crit Care 19: 71, 2015.
32.

Kern TS, Du Y, Miller CM, Hatala DA, and Levin LA. Overexpression of

Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic
retinopathy. Am J Pathol 176: 2550-2558, 2010.
33.

Kumari A, Iwasaki T, Pyndiah S, Cassimere EK, Palani CD, and

Sakamuro D. Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.
Cell Death Differ 22: 311-322, 2015.
34.

Leipnitz G, Mohsen AW, Karunanidhi A, Seminotti B, Roginskaya VY,

Markantone DM, Grings M, Mihalik SJ, Wipf P, Van Houten B, and Vockley
J. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulummitochondria crosstalk, and reactive oxygen species in fibroblasts from patients
with complex I deficiency. Sci Rep 8: 1165, 2018.
35.

Li H, Cui H, Kundu TK, Alzawahra W, and Zweier JL. Nitric oxide

production from nitrite occurs primarily in tissues not in the blood: critical role of
xanthine oxidase and aldehyde oxidase. J Biol Chem 283: 17855-17863, 2008.
36.

Li M, Zhang P, Wei HJ, Li MH, Zou W, Li X, Gu HF, and Tang XQ.

Hydrogen Sulfide Ameliorates Homocysteine-Induced Cognitive Dysfunction by
Inhibition of Reactive Aldehydes Involving Upregulation of ALDH2. Int J
Neuropsychopharmacol 20: 305-315, 2017.
37.

Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, and Musi N.

Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
PLoS One 8: e63983, 2013.

53
38.

Liu C, Stonestrom AJ, Christian T, Yong J, Takase R, Hou YM, and

Yang X. Molecular Basis and Consequences of the Cytochrome c-tRNA
Interaction. J Biol Chem 291: 10426-10436, 2016.
39.

Liu XR, Cao L, Li T, Chen LL, Yu YY, Huang WJ, Liu L, and Tan XQ.

Propofol attenuates H2O2-induced oxidative stress and apoptosis via the
mitochondria- and ER-medicated pathways in neonatal rat cardiomyocytes.
Apoptosis 22: 639-646, 2017.
40.

Liu Y, and Chen XJ. Adenine nucleotide translocase, mitochondrial

stress, and degenerative cell death. Oxid Med Cell Longev 2013: 146860, 2013.
41.

Lofrumento DD, La Piana G, Abbrescia DI, Palmitessa V, La Pesa V,

Marzulli D, and Lofrumento NE. Valinomycin induced energy-dependent
mitochondrial swelling, cytochrome c release, cytosolic NADH/cytochrome c
oxidation and apoptosis. Apoptosis 16: 1004-1013, 2011.
42.

Malinska D, Mirandola SR, and Kunz WS. Mitochondrial potassium

channels and reactive oxygen species. FEBS Lett 584: 2043-2048, 2010.
43.

McCommis KS, and Baines CP. The role of VDAC in cell death: friend or

foe? Biochim Biophys Acta 1818: 1444-1450, 2012.
44.

McMurray F, Patten DA, and Harper ME. Reactive Oxygen Species and

Oxidative Stress in Obesity-Recent Findings and Empirical Approaches. Obesity
(Silver Spring) 24: 2301-2310, 2016.
45.

Meyrick B, Hoover R, Jones MR, Berry LC, Jr., and Brigham KL. In

vitro effects of endotoxin on bovine and sheep lung microvascular and pulmonary
artery endothelial cells. J Cell Physiol 138: 165-174, 1989.

54
46.

Mula RV, Machiah D, Holland L, Wang X, Parihar H, Sharma AC,

Selvaraj P, and Shashidharamurthy R. Immune Complex-Induced, Nitric
Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented
with Decoy FcgammaReceptors. PLoS One 11: e0153620, 2016.
47.

Nathan C, and Cunningham-Bussel A. Beyond oxidative stress: an

immunologist's guide to reactive oxygen species. Nat Rev Immunol 13: 349-361,
2013.
48.

Parthasarathy G, and Philipp MT. Review: apoptotic mechanisms in

bacterial infections of the central nervous system. Front Immunol 3: 306, 2012.
49.

Raza H, John A, and Shafarin J. Potentiation of LPS-Induced Apoptotic

Cell Death in Human Hepatoma HepG2 Cells by Aspirin via ROS and
Mitochondrial Dysfunction: Protection by N-Acetyl Cysteine. PLoS One 11:
e0159750, 2016.
50.

Rosadini CV, and Kagan JC. Early innate immune responses to bacterial

LPS. Curr Opin Immunol 44: 14-19, 2017.
51.

Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, and

Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9:
49-89, 2007.
52.

Sam AD, 2nd, Sharma AC, Law WR, and Ferguson JL. Splanchnic

vascular control during sepsis and endotoxemia. Front Biosci 2: e72-92, 1997.
53.

Sam AD, 2nd, Sharma AC, Rice AN, Ferguson JL, and Law WR.

Adenosine and nitric oxide regulate regional vascular resistance via

55
interdependent and independent mechanisms during sepsis. Crit Care Med 28:
1931-1939, 2000.
54.

Shakeri R, Kheirollahi A, and Davoodi J. Apaf-1: Regulation and

function in cell death. Biochimie 135: 111-125, 2017.
55.

Sharma AC. Sepsis-induced myocardial dysfunction. Shock 28: 265-269,

2007.
56.

Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR,

and Ferguson JL. Sepsis alters myocardial and plasma concentrations of
endothelin and nitric oxide in rats. J Mol Cell Cardiol 29: 1469-1477, 1997.
57.

Sharma AC, Sam AD, 2nd, Lee LY, Hales DB, Law WR, Ferguson JL,

and Bosmann HB. Effect of NG-nitro-L-arginine methyl ester on testicular blood
flow and serum steroid hormones during sepsis. Shock 9: 416-421, 1998.
58.

Shioiri T, Muroi M, Hatao F, Nishida M, Ogawa T, Mimura Y, Seto Y,

Kaminishi M, and Tanamoto K. Caspase-3 is activated and rapidly released
from human umbilical vein endothelial cells in response to lipopolysaccharide.
Biochim Biophys Acta 1792: 1011-1018, 2009.
59.

Shvetsova AN, Mennerich D, Keratar JM, Hiltunen JK, and Kietzmann

T. Non-electron transfer chain mitochondrial defects differently regulate HIF1alpha degradation and transcription. Redox Biol 12: 1052-1061, 2017.
60.

Smith KA, Waypa GB, and Schumacker PT. Redox signaling during

hypoxia in mammalian cells. Redox Biol 13: 228-234, 2017.

56
61.

Snyder CM, Shroff EH, Liu J, and Chandel NS. Nitric oxide induces cell

death by regulating anti-apoptotic BCL-2 family members. PLoS One 4: e7059,
2009.
62.

Soufli I, Toumi R, Rafa H, and Touil-Boukoffa C. Overview of cytokines

and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel
diseases. World J Gastrointest Pharmacol Ther 7: 353-360, 2016.
63.

Suzuki Y, Hasegawa H, Tsuji T, Tsuruda K, Sasaki D, Ishihara K,

Nagai K, Yanagihara K, Yamada Y, and Kamihira S. Relationships of diverse
apoptotic death process patterns to mitochondrial membrane potential
(Deltapsi(m)) evaluated by three-parameter flow cytometric analysis.
Cytotechnology 65: 59-70, 2013.
64.

Um HD. Bcl-2 family proteins as regulators of cancer cell invasion and

metastasis: a review focusing on mitochondrial respiration and reactive oxygen
species. Oncotarget 7: 5193-5203, 2016.
65.

Wang C, and Youle RJ. The role of mitochondria in apoptosis*. Annu Rev

Genet 43: 95-118, 2009.
66.

Wang Y, Wang Y, Yang D, Yu X, Li H, Lv X, Lu D, and Wang H. beta(1)-

adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis
through activating PKA and enhancing CaMKII and IkappaBalpha
phosphorylation. Crit Care 19: 76, 2015.
67.

Ward PA. Sepsis, apoptosis and complement. Biochem Pharmacol 76:

1383-1388, 2008.

57
68.

Wheeler DS. Death to sepsis: targeting apoptosis pathways in sepsis. Crit

Care 13: 1010, 2009.
69.

Williams LJ, Nye BG, and Wende AR. Diabetes-Related Cardiac

Dysfunction. Endocrinol Metab (Seoul) 32: 171-179, 2017.
70.

Yang X, Cohen MV, and Downey JM. Mechanism of cardioprotection by

early ischemic preconditioning. Cardiovasc Drugs Ther 24: 225-234, 2010.
71.

Zhang M, Wang S, Cheng Z, Xiong Z, Lv J, Yang Z, Li T, Jiang S, Gu

J, Sun D, and Fan Y. Polydatin ameliorates diabetic cardiomyopathy via Sirt3
activation. Biochem Biophys Res Commun 493: 1280-1287, 2017.
72.

Zhang M, Zheng J, Nussinov R, and Ma B. Release of Cytochrome C

from Bax Pores at the Mitochondrial Membrane. Sci Rep 7: 2635, 2017.
73.

Zhong H, Xiao M, Zarkovic K, Zhu M, Sa R, Lu J, Tao Y, Chen Q, Xia

L, Cheng S, Waeg G, Zarkovic N, and Yin H. Mitochondrial control of apoptosis
through modulation of cardiolipin oxidation in hepatocellular carcinoma: A novel
link between oxidative stress and cancer. Free Radic Biol Med 102: 67-76, 2017.
74.

Ziello JE, Jovin IS, and Huang Y. Hypoxia-Inducible Factor (HIF)-1

regulatory pathway and its potential for therapeutic intervention in malignancy
and ischemia. Yale J Biol Med 80: 51-60, 2007.

